SOPHiA GENETICS
PublicSOPHiA GENETICS is now publicly traded
The data on this page reflects SOPHiA GENETICS's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 22, 2021
Last Round
Private Placement
Jul 27, 2021
Est. Valuation at Exit
$1.14B
Total Funding Raised
$502.55M
Company Overview
SOPHiA GENETICS is a healthcare technology company that provides a cloud-native SaaS platform, SOPHiA DDM™, dedicated to advancing data-driven medicine. The platform utilizes AI and machine learning to analyze complex multimodal data sets, including genomic and radiomic data, to generate actionable insights for healthcare providers, laboratories, and biopharmaceutical institutions. Founded in 2011 as a startup from the École Polytechnique Fédérale de Lausanne (EPFL), the company aims to democratize precision medicine for oncology, rare diseases, cardiology, and other conditions. By connecting a global network of institutions, the platform fosters collective intelligence while allowing users to maintain control of their data. SOPHiA GENETICS went public in July 2021 and is traded on the Nasdaq (SOPH). The company serves customers in over 70 countries and has dual headquarters in Rolle, Switzerland, and Boston, USA.
Sector
Healthcare
AI Layer
Application
Keywords
SOPHiA GENETICS Comparables
Compare SOPHiA GENETICS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SeqOne | 79% | |
| Caris Life Sciences | 76% | |
| Geneyx | 75% | |
SOPHiA GENETICS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 27, 2021 | ||||
| IPO | Jul 22, 2021 | ||||
| Series F | Oct 1, 2020 | ||||
| Series E | Jan 4, 2019 | ||||
| Series D | Sep 13, 2017 | ||||
Series C | Dec 16, 2015 |
Key People
Founding team and executive leadership
SOPHiA GENETICS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 360 Capital | Series D |
| Pictet Group | Series F |
| Idinvest Partners | Series E |
| Swisscom Ventures | Series F |
| HV Fund | Series F |
| 360 Capital | Series D |
| Al-Nahdi | Series F |
SOPHiA GENETICS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
